FDA Inspection 819593 — Janssen Vaccines, Zweigniederlassung Der Cilag GmbH International
The FDA completed an inspection of Janssen Vaccines, Zweigniederlassung Der Cilag GmbH International on Dec 7, 2012 in Bern. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 7, 2012
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Bern (Switzerland)